View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab 6 / Cisplatin 80 / Fluorouracil 800, adenocarcinoma esophagogastric junction and stomach, cycle 2+
Protocol-ID: 140 V1.3 (Mini), TRAS6/CISP80/FU800, AEG/Gastric Ca, C2+Indication(s)
- Gastric Cancer (HER2+); ICD-10 C16.-, C16.0
- Esophageal Cancer (Adenocarcinoma Esophagogastric Junction (AEG), HER2+); ICD-10 C15.-
Links
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.02.2023